ANYARA

Related by string. * * Anyara Emukule . Mathew Anyara Emukule *

Related by context. All words. (Click for frequent words.) 69 IMA# 69 proteasome inhibitor 69 Nexavar ® 68 sorafenib tablets 68 radiation sensitizer 68 Panzem R 68 Phase #b/#a clinical 68 MAGE A3 ASCI 68 PLK1 SNALP 67 Xeloda ® 67 Panzem R NCD 67 targeted radiotherapeutic 67 Ixabepilone 67 Temsirolimus 67 PDX pralatrexate 67 refractory chronic lymphocytic 67 PrevOnco 67 YONDELIS 67 ® bortezomib 66 huC# DM4 66 Daclizumab 66 R sorafenib tablets 66 Xanafide 66 Voreloxin 66 XL# anticancer compounds 66 Solazed TM 66 RhuDex ® 66 Gemzar ® 66 trastuzumab DM1 T DM1 66 NEBIDO R 66 PDE4 inhibitor 66 Aflibercept 66 dasatinib Sprycel ® 66 PI3K/Akt pathway inhibitor 66 interferon gamma 1b 65 histone deacetylase HDAC inhibitor 65 Tezampanel 65 orally administered inhibitor 65 FOLOTYN ® 65 DOS# 65 Vandetanib 65 Squalamine 65 evaluating satraplatin 65 erlotinib Tarceva ® 65 volociximab 65 INCB# [001] 65 Azedra 65 mifamurtide 65 BRIM2 65 Clolar ® 65 Archexin 65 CB2 selective receptor agonist 65 Homspera TM 65 IAP inhibitors 65 MGd 65 hypoxia activated prodrug 65 ATL# [001] 65 NPC 1C 65 Safinamide 65 liposomal formulation 65 mertansine 65 oral proteasome inhibitor 65 GW# [003] 65 dextromethorphan quinidine 65 paclitaxel Taxol ® 65 ularitide 65 Intravenous CP 65 PEGylated Fab fragment 65 investigational humanized monoclonal antibody 65 Aplidin 64 Quinamed 64 Pimavanserin 64 phase IIa clinical 64 doxorubicin Transdrug ® 64 Allovectin 7 64 Azedra ™ 64 Bezielle 64 evaluating tivozanib 64 HER2 positive metastatic breast 64 rasagiline tablets 64 XL# XL# 64 oral ridaforolimus 64 R bortezomib 64 seliciclib CYC# 64 QUADRAMET R 64 mitogen activated ERK kinase 64 Velcade bortezomib 64 lexidronam injection 64 tiapamil 64 Amrubicin 64 PNP inhibitor 64 Fludara ® 64 JAK inhibitors 64 alvespimycin 64 Campath ® 64 CR# vcMMAE 64 PSMA ADC 64 sorafenib Nexavar 64 LEUKINE 64 trastuzumab Herceptin R 64 Aurexis 64 receptor tyrosine kinase inhibitor 64 novel VDA molecule 64 corticotropin injection 64 PF # [002] 64 SPRYCEL ® 64 SinuNase ™ 64 Zorbtive TM 64 AQ4N 64 cleavable linker 64 AVONEX ® 64 Troxatyl 64 Interferon beta 1a 64 Pemetrexed 64 CD# antibody [001] 64 sunitinib Sutent ® 64 thalidomide Thalomid 64 beta 1a 64 humanized anti 64 multi kinase inhibitor 64 ocular formulation 64 Allovectin 7 ® 64 targeted antifolate 64 BLP# Liposome Vaccine 64 CD3 monoclonal antibody 64 metastatic hormone refractory 64 Gel repository corticotropin injection 64 calcineurin inhibitors 64 LHRH antagonist 64 Taxotere ® 64 pertuzumab 64 Peginterferon alfa 2b 64 oral prodrug 64 Glufosfamide 64 aflibercept 64 EndoTAG TM -1 64 sunitinib malate 64 phase IIb clinical 64 vidofludimus 63 Neulasta ® 63 2 methoxyestradiol 63 Onalta 63 Solazed 63 JAK inhibitor 63 topically applied SEPA 63 Neupogen ® 63 Leukine ® 63 BCR ABL inhibitors 63 Allovectin 7 R 63 thetreatment 63 gallium nitrate injection 63 advanced metastatic prostate 63 Ixempra 63 Paraplatin ® 63 Genasense ® 63 CTAP# Capsules 63 sapropterin dihydrochloride 63 metastatic castration resistant 63 IgG1 monoclonal antibody 63 Vitaxin 63 ZACTIMA 63 TAFA# 63 metaglidasen 63 PD LID 63 CYT# potent vascular disrupting 63 Besivance 63 Aplidin R 63 IL# PE#QQR 63 PROSTASCINT R 63 LymphoStat B belimumab 63 Hsp# Inhibitor 63 Degarelix 63 R brand eszopiclone 63 Cloretazine ® 63 ixabepilone 63 Ocrelizumab 63 Bortezomib 63 ZOLINZA 63 FUSILEV ® 63 Zenvia TM 63 Alfacell proprietary ribonuclease 63 vinca alkaloids 63 acyclovir Lauriad R 63 HCV protease inhibitor 63 non nucleoside inhibitor 63 IMiDs R 63 rNAPc2 63 Bicifadine 63 tubulin inhibitor 63 MOZOBIL 63 toenail onychomycosis 63 gemcitabine cisplatin 63 Solzira ™ 63 MKC# MKC# PP 63 elotuzumab 63 TASQ 63 Iloperidone 63 Aurora kinase inhibitor 63 peripherally acting 63 BRAF inhibitor 63 oral picoplatin 63 virus HCV protease inhibitor 63 pan HDAC inhibitor 63 IIa trial 63 hormone LHRH antagonist 63 Phase 1b clinical trials 63 leading oral taxane 63 Cx# [002] 63 Rebif ® 63 Carfilzomib 63 thymalfasin 63 ALN PCS 63 Irinotecan 63 enzastaurin 63 sarcoma melanoma 63 OvaRex R 63 essential thrombocythemia ET 63 vinorelbine tartrate 63 Onco TCS 63 Zemiva ™ 63 CDK cyclin dependent 63 Completes Patient Enrollment 63 AEG# 63 YONDELIS R 63 OPAXIO 63 Azedra TM 63 Anavex #-# 63 antibody MAb 63 Neulasta R 63 forodesine 63 vorinostat 63 pralatrexate injection folate analogue 63 drug pipeline TAFA# 63 modulator SERM 63 novel histone deacetylase 63 PrevOnco ™ 62 hypoxia selective 62 PEG SN# 62 neratinib 62 XYOTAX TM 62 TKB# 62 treat chronic sinusitis 62 stable nucleic acid 62 MOVIPREP R 62 P#X# antagonist 62 Tanespimycin 62 Omnitarg 62 Onalta ™ 62 Neuradiab 62 bortezomib Velcade 62 relapsed leukemia 62 COLAZAL R 62 SinuNase TM 62 vapreotide acetate 62 induced macular edema 62 Phase IIb Clinical Trial 62 XL# XL# XL# 62 HDAC Inhibitor 62 Pralatrexate 62 Trofex TM 62 docetaxel Taxotere 62 INSPIRE Trial Phase III 62 GAMMAGARD 62 sapacitabine CYC# 62 BCX# 62 selective immunoproteasome inhibitor 62 Erlotinib 62 ELACYT 62 HCD# [002] 62 Afatinib 62 deforolimus 62 gemcitabine chemotherapy 62 EndoTAG TM 62 Tamibarotene 62 Tesetaxel 62 ONCASPAR 62 Azixa 62 mTOR inhibitor 62 OvaRex ® MAb 62 Dalbavancin 62 recurrent NSCLC 62 Guanilib 62 Darinaparsin 62 Hedgehog Pathway Inhibitor 62 evaluating picoplatin 62 TELINTRA 62 targeting CD# 62 modified glutathione analog 62 OMNARIS HFA 62 Palifosfamide 62 rheumatoid arthritis thrombocytopenia 62 bevacizumab Avastin ® 62 ALN VSP 62 Phase Ib study 62 Davunetide 62 selective modulator 62 cetuximab Erbitux R 62 6R BH4 62 FOLFOX6 chemotherapy regimen 62 Zemiva TM 62 infusional 5-FU/LV 62 Vicinium TM 62 DOXIL 62 TLR9 agonists 62 Loramyc R 62 dasatinib Sprycel 62 MEK Inhibitor 62 reslizumab 62 Combination REOLYSIN R 62 EOquin 62 erlotinib Tarceva 62 pseudobulbar affect PBA 62 EFAPROXYN 62 Phase #/#a trial 62 SNT MC# 62 ThermoDox ® clinical 62 investigational immunotherapy 62 imatinib Gleevec ® 62 hyaluronidase enzyme 62 pancreatic prostate 62 Personalized Immunotherapy 62 sargramostim 62 Thalomid ® 62 Fulvestrant 62 Phase 2a Clinical Trial 62 Serostim R 62 Alocrest 62 anticancer compound 62 Panzem NCD 62 lintuzumab SGN 62 Anturol TM 62 Onconase 62 immunomodulating 62 Elvitegravir 62 CD# CEA 62 TASKi2 62 MEK inhibitors 62 MEK inhibitor 62 unique alkylating agent 62 alemtuzumab Campath 62 HGS ETR1 62 KNS # 62 Factor VIIa 62 NTDDS 62 psoriasis rheumatoid arthritis 62 acetonide FA 62 tosedostat 62 Proxinium TM 62 docetaxel Taxotere R 62 ZEVALIN ® 62 custirsen 62 PXD# 62 Mitoxantrone 62 AZD# 62 developing Bicifadine serotonin 62 Herceptin trastuzumab 62 ThermoDox R 62 selective kinase inhibitor 62 luteinizing hormone releasing 62 Traficet EN 62 DexaSite 62 opioid induced bowel dysfunction 62 depsipeptide 61 evaluating REVLIMID 61 VISICOL R 61 RAV# 61 tanespimycin 61 Tarceva TM 61 antibody MT# 61 Phase Ib II 61 lenalidomide Revlimid R 61 CCX# 61 HuLuc# 61 Phase 2b Clinical Trial 61 metastatic castrate resistant 61 vitreoretinal disorders 61 RNAi Therapeutic 61 Meets Primary Endpoint 61 Adenoscan R 61 Silodosin 61 isoform selective 61 intravesical infusion therapy 61 THR beta agonist 61 Lenocta 61 temsirolimus 61 IMiDs 61 cediranib 61 CCX# B 61 Curaxin 61 Perforomist ™ Inhalation Solution 61 adecatumumab 61 EXPAREL ™ 61 LEVADEX TM 61 acyclovir Lauriad ® 61 Revlimid lenalidomide 61 MyVax R 61 Bendamustine 61 dependent kinase inhibitor 61 rHuPH# recombinant human 61 Phase IIb clinical trials 61 AAG geldanamycin analog 61 GVAX ® 61 Fibrillex TM 61 Vinorelbine 61 novel oral anticoagulant 61 phase III isavuconazole 61 HGS ETR2 61 VAPRISOL 61 synthetic retinoid 61 Cleviprex TM clevidipine 61 Lubiprostone 61 Curaxin CBLC# 61 Testim R 61 HSP# inhibitor 61 Ceflatonin R 61 Intravenous Human 61 oral dual endothelin 61 PNT# 61 Solazed ™ 61 mGluR5 NAM 61 Kuvan sapropterin dihydrochloride 61 Romidepsin 61 Cetrorelix 61 rxRNA 61 octreotide implant 61 Zybrestat 61 Ceflatonin 61 MAP# 61 Nanobody 61 class anticancer quinolone 61 IMiDs ® 61 CAMPATH 61 Ambrisentan 61 trastuzumab DM1 61 fosbretabulin 61 Fludara 61 adenosine injection 61 TMC# [002] 61 ospemifene 61 PKC# 61 Phase Ib IIa 61 INTEGRILIN ® 61 TNF Tumor Necrosis Factor 61 IMC #B 61 Oracea TM 61 ARRY # 61 CIMZIA ™ 61 Microspheres 61 PEGASYS ® 61 Argatroban 61 Pafuramidine 61 diabetic neuropathic pain 61 Taxotere chemotherapy 61 Zenvia ™ 61 alvimopan 61 Chemophase 61 AzaSite Plus 61 Perifosine 61 small molecule Hedgehog 61 cutaneous T cell 61 orally bioavailable 61 IMiDs ® compound 61 AKT inhibitor 61 nalbuphine ER 61 Ofatumumab 61 registrational trial 61 plasma kallikrein inhibitor 61 alpha folate receptor 61 TRIOLEX HE# APOPTONE HE# 61 Soliris TM eculizumab 61 Excellarate TM 61 biologic therapy 61 relapsed refractory multiple myeloma 61 herpetic keratitis 61 estrogen receptor antagonist 61 TREANDA 61 Immunotherapeutic 61 Cloretazine R VNP#M 61 Sudhir Agrawal D.Phil 61 highly selective inhibitor 61 Phase IIB 61 humanized monoclonal antibody 61 PRT# 61 Talabostat 61 incyclinide 61 rheumatoid arthritis psoriasis 61 tezampanel 61 UPLYSO 61 Navelbine ® 61 BEMA TM Fentanyl 61 AVASTIN 61 R lenalidomide 61 Tarceva erlotinib 61 PROVENGE ® 61 Natalizumab 61 Iluvien ® 61 HGS# 61 Levoleucovorin 61 JAK1 61 Belinostat 61 ara C 61 Optiquel ™ 61 Vaprisol 61 overactive bladder AA# 61 immune modulatory 61 PEGylated anti 61 D aspartate NMDA receptor 61 include PLX IBD 61 ALN TTR 61 Altera Nebulizer System 61 Cimzia TM 61 xanthine oxidase inhibitor 61 XmAb# 61 alpha interferons 61 Vectibix panitumumab 61 Enzastaurin 61 Panzem 61 T DM1 61 XP# XP# 61 somatostatin analogue 61 Laquinimod 61 budesonide foam 61 IAP inhibitor 61 OncoVEX GM CSF 61 Phase 2b clinical 61 Soliris eculizumab 60 low dose cytarabine 60 Targretin 60 topical ophthalmic 60 MKC# MT 60 R#/MEM # 60 5 FU leucovorin 60 PREOS R 60 cardiometabolic diseases Glucophage 60 Zevalin R Ibritumomab 60 candidates Azedra 60 Clofarabine 60 Trabectedin 60 Ozarelix 60 anti angiogenic agent 60 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 60 Phase Ib Clinical Trial 60 trabectedin 60 Soriatane 60 INCB# [003] 60 SinuNase 60 Serostim ® 60 GSK# [001] 60 Aztreonam lysine 60 NeoLipid R 60 polymerase inhibitor 60 cancer neuroendocrine tumor 60 generation purine nucleoside 60 demonstrated antitumor activity 60 Elagolix 60 5 HT6 60 BAY #-# 60 delivers fluocinolone acetonide FA 60 R roscovitine CDK cyclin 60 initiated Phase Ib 60 Aeroquin 60 advanced metastatic renal 60 IV Busulfex 60 MGCD# [001] 60 MT#/MEDI-# 60 Elotuzumab 60 Polymer Microspheres 60 induced mucositis 60 Synavive 60 methylnaltrexone bromide 60 cutaneous T 60 XL# XL# XL# XL# 60 BRIM3 60 Nexavar sorafenib 60 Raptiva ® 60 selective androgen receptor modulator 60 Phase Ib clinical trials 60 LEP ETU 60 etanercept Enbrel 60 intravesical instillation 60 EGS# 60 Bazedoxifene 60 abatacept Orencia 60 Phase 2a clinical 60 Familial Adenomatous Polyposis FAP 60 Phase IIb Trial 60 Insegia 60 investigational monoclonal antibody 60 ITAX 60 paclitaxel Taxol 60 formerly LymphoStat B 60 Aviptadil 60 refractory AML 60 BEMA Buprenorphine 60 topical gel formulation 60 Epratuzumab 60 Frova ® 60 docetaxel Taxotere ® 60 Onyx Pharmaceuticals Announces 60 Copegus R 60 Abiraterone acetate 60 Pivotal Phase III 60 Exelixis compounds 60 ACTEMRA TM 60 teriflunomide 60 cetuximab Erbitux 60 TG# [003] 60 taxane derivative 60 ulimorelin 60 Study Evaluating 60 Trofex 60 Dapagliflozin 60 Litx 60 BENLYSTA ® 60 bevacizumab Avastin 60 Saizen R 60 ABILIFY R 60 DORIBAX 60 novel peptide 60 Solzira TM 60 Crofelemer budesonide foam 60 Pradefovir 60 Phase 2b clinical trials 60 OncoGel 60 generation URAT1 inhibitor 60 Proellex TM 60 Evoltra ® 60 SAR# [004] 60 bortezomib Velcade R 60 RECOTHROM R 60 investigational antiplatelet agent 60 CEQ# 60 Doxil 60 ALN HPN 60 Telatinib 60 memantine HCl 60 including eniluracil ADH 60 Relivar 60 Dacogen decitabine 60 GVAX R 60 pralatrexate 60 cell lymphoma CTCL 60 anti EGFR antibody 60 LHRH antagonists 60 EP #R 60 Inhalation Solution 60 Pirfenidone 60 AeroLEF TM 60 REOLYSIN ® 60 Jevtana 60 EOquin TM 60 Annamycin 60 RGB # 60 TLK# 60 Zolinza 60 tezampanel NGX# 60 recurrent metastatic ovarian cancer 60 nilotinib Tasigna ® 60 Ecallantide 60 gemcitabine Gemzar 60 Fodosine 60 HQK 60 sodium glucose cotransporter 60 markets HP Acthar 60 Junovan TM 60 fluoropyrimidine 60 product platforms AZX# 60 denileukin diftitox 60 somatostatin analog 60 Cariprazine 60 Qutenza TM 60 seliciclib 60 GVAX immunotherapy 60 R Saizen R 60 JAK2 inhibitor 60 RhuDex 60 Liposomal 60 ANTEGREN 60 BYETTA ® 60 vaccines oncolytic virus 60 TYKERB 60 Receives Orphan Drug Designation 60 Granulocyte Colony Stimulating Factor 60 Xcytrin R 60 phase IIb trial 60 oncolytic virus therapies 60 Genasense ® oblimersen 60 immunotherapeutic agent 60 Phase IIa trials 60 OXi# 60 oncolytic viruses 60 TOCOSOL Paclitaxel 60 Veregen TM 60 Vidaza azacitidine 60 5 FU capecitabine 60 severe hypercholesterolemia 60 Entereg R 60 Cloretazine 60 TRAIL receptor antibodies 60 Catena ® 60 advanced carcinoid 60 motexafin gadolinium Injection 60 relapsed multiple myeloma 60 Phase 2a Trial 60 Dyloject TM 60 aclidinium bromide 60 generation nucleoside analog 60 miconazole Lauriad ® 60 SUPPRELIN R LA 60 Alzheimer disease cognitive impairment 60 HMG CoA reductase inhibitors 60 NOX E# 60 Bafetinib 60 rufinamide 60 Junovan 60 FUSILEV enhances 60 Kuvan R 60 liposomal doxorubicin 60 lintuzumab 60 Androxal TM 60 small molecule chemotherapeutic 60 FGFR 60 cetuximab Erbitux ® 60 OMNARIS Nasal Spray 60 myelofibrosis polycythemia vera 60 protein tyrosine phosphatase 1B 60 next generation URAT1 60 anti amnesic 60 efalizumab 60 ALN TTR# 60 galiximab 60 samarium Sm 60 veltuzumab 60 VitiGam 60 Filgrastim 60 Xcellerated T Cells 60 HuMax CD4 59 TBC# 59 alkylating agent 59 RH1 59 agonistic human 59 IMGN# 59 confirmatory Phase III 59 LUNESTA TM 59 DEB# 59 Pivotal Phase 59 Ciclesonide 59 Golimumab 59 Pegasys ® 59 polymerase inhibitors 59 Orapred ODT 59 molecular imaging radiopharmaceutical 59 Oracea ® 59 TORISEL 59 castrate resistant prostate cancer 59 oncology indications 59 Civacir 59 Microplasmin 59 Pathway Inhibitor 59 Amplimexon 59 nilotinib Tasigna 59 #D#C# 59 CCR9 antagonist 59 BioNeutral antimicrobial formulations 59 PGL# 59 ongoing Phase 1b 59 Myocet 59 somatropin Kuvan R 59 TNFerade TM 59 Capesaris 59 evaluating Xcytrin 59 Epothilones 59 Nutra Pharma wholly owned 59 Vidaza ® 59 TKM ApoB 59 NVA# 59 HuMax EGFr 59 Mycophenolate Mofetil 59 ALVESCO R 59 compound INCB# 59 NXL# 59 Virulizin R 59 DAVANAT R 59 LymphoStat B 59 NovaBay Aganocide compounds 59 kidney urologic 59 Yondelis ® 59 hormone agonist 59 NGX# 59 Aloxi injection 59 KRN# 59 L BLP# 59 Arimoclomol 59 compound AEZS 59 Cimzia ® certolizumab pegol 59 Pruvel ™ 59 Avastin bevacizumab 59 Increlex R 59 EGFR expressing mCRC 59 orally inhaled 59 goserelin 59 Lu AA# 59 Cannabinor 59 GV# [001] 59 lipid nanoparticle 59 Diamyd ® 59 STEDESA 59 entinostat 59 axitinib 59 Kamada AAT 59 R bendamustine hydrochloride 59 Vimpat R 59 Alinia 59 UVIDEM 59 monoclonal antibody conjugated 59 Clevudine 59 L MTP PE 59 TASKi3 59 novel topoisomerase 59 MTP inhibitor 59 HepeX B TM 59 R metformin Concor 59 Disease IBD 59 Bicalutamide 59 Imprime PGG 59 diabetes irritable bowel 59 Nimotuzumab 59 Dacogen injection 59 OPAXIO TM 59 OMP #M# 59 Granted Orphan Drug 59 AQD class 59 HGS ETR1 mapatumumab 59 TOCOSOL Camptothecin 59 LymphoStat B TM 59 selective adenosine 59 RELOVAIR ™ 59 sulodexide 59 palifosfamide Zymafos TM 59 Serdaxin ® 59 telomerase therapeutic 59 Plicera 59 Liprotamase 59 humanized monoclonal 59 Trastuzumab DM1 59 romidepsin 59 MYDICAR ® 59 IMC A# 59 Tofacitinib 59 diarrhea predominant irritable 59 Phase III Clinical Trial 59 Phase Ib 59 decitabine 59 CDP# 59 oral beclomethasone dipropionate 59 R#/MEM 59 ZEFTERA TM Zevtera TM 59 vinca alkaloid 59 refractory multiple myeloma 59 non nucleoside HCV 59 mapatumumab 59 Aryplase 59 angiogenesis inhibitor 59 doxorubicin HCl liposome injection 59 PROSTVAC TM 59 terlipressin 59 GALNS 59 febuxostat 59 FROVA 59 Diabetic Macular Edema 59 GRN# 59 tramiprosate Alzhemed TM 59 anti CD# antibodies 59 ZYBRESTAT fosbretabulin 59 huN# DM1 59 chimeric monoclonal antibody 59 Dose Escalation 59 catheter occlusion 59 ferumoxytol Injection 59 laquinimod 59 regadenoson 59 EGFR HER2 59 Rescula 59 tafamidis 59 GTC recombinant human 59 pain palliation 59 ZYBRESTAT 59 XAGRID 59 Pazopanib 59 Teysuno 59 Randomized Phase 59 APOPTONE 59 HERmark 59 Pharmacokinetics PK 59 Selective Electrochemical Tumor Ablation 59 Simulect 59 Monoclonal antibody 59 Denufosol 59 VALSTAR 59 DNA methyltransferase inhibitors 59 CCR5 antagonist 59 Zavesca r 59 Oncaspar 59 ZADAXIN 59 Romiplostim 59 IMiD 59 ONTAK 59 Phase III Pivotal 59 Indaflex TM 59 labial herpes 59 Asentar 59 Selective Internal 59 CAELYX 59 inhaled formulation 59 Urocidin TM 59 Debio 59 proteasome inhibitors 59 Kevetrin ™ 59 Sapacitabine 59 prucalopride 59 nitric oxide donating 59 NEUGENE 59 BCR ABL inhibitor 59 ASCO GI 59 VEGF Trap 59 Exherin TM 59 sumatriptan DosePro 59 trastuzumab emtansine T DM1 59 Symadex 59 neuropathic pain spasticity 59 Inhalation Aerosol 59 Methylnaltrexone 59 PEGylated interferon beta 1a 59 peptidic compound 59 Omacetaxine 59 investigational oral inhibitor 59 PS# [001] 59 adalimumab Humira 59 generation proteasome inhibitor 59 eTag assays 59 CYC# 59 ENMD # 59 Wafer polifeprosan 59 Panzem ® 59 Targretin capsules 59 novel immunomodulatory 59 EVIZON TM squalamine lactate 59 carboplatin paclitaxel 59 TRANSDUR ™ 59 octreotide acetate 59 arsenic trioxide injection 59 LUVENIQ 59 selective phosphodiesterase 59 Hycamtin 59 Pruvel TM 59 Ophena TM 59 ASONEP 59 Cathepsin S 59 anticancer agent 59 VEGFR2 inhibitor 59 BR.# 59 Gabapentin GR 59 APEX PD 59 brand ciclesonide HFA 59 glufosfamide 59 ZFP Therapeutics 59 Atiprimod 59 immunosuppressive compound 59 Lupus Nephritis 58 5 HT3 antagonist 58 PHX# 58 Achieves Primary Endpoint 58 Stedivaze 58 sorafenib Nexavar ® 58 Xyrem ® 58 sulfonylhydrazine class 58 omega interferon 58 selective A2A adenosine receptor 58 SERMs 58 Initiates Enrollment 58 Anidulafungin 58 Neurodex 58 Sym# 58 lorvotuzumab mertansine 58 recurrent GBM 58 Actimmune ® 58 Oxypurinol 58 Pruvel 58 vascular disrupting agents 58 PROCHYMAL 58 PANVAC VF 58 intranasal formulation 58 histone deacetylase HDAC 58 Everolimus 58 MDV# 58 orally bioavailable mimics 58 gemcitabine Gemzar ® 58 CBLC# 58 pradefovir

Back to home page